Laurus Labs Limited
LAURUSLABS
Classement en actions
#1774
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Prix de l'action
$22.43
Capitalisation boursière
$12.12B
Changement (1 jour)
-1.76%
Changement (1 an)
113.71%
Pays
IN
Échange Laurus Labs Limited (LAURUSLABS)
Catégorie
Healthcare
Revenus pour Laurus Labs Limited (LAURUSLABS)
Revenus en Jun 2026 TTM : $802.27M
Selon les derniers rapports financiers de Laurus Labs Limited, le chiffre d'affaires actuel de l'entreprise (TTM) est de $802.27M. En 2024, l'entreprise a réalisé un chiffre d'affaires de $604.54M une diminution par rapport à le chiffre d'affaires de l'année 2023, qui était de $735.03M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Laurus Labs Limited de 2013 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $802.27M | 23.54% |
| 2025 | $649.39M | 7.42% |
| 2024 | $604.54M | -17.75% |
| 2023 | $735.03M | 13.05% |
| 2022 | $650.19M | -1.12% |
| 2021 | $657.55M | 74.93% |
| 2020 | $375.88M | 13.88% |
| 2019 | $330.06M | 4.51% |
| 2018 | $315.80M | 7.52% |
| 2017 | $293.70M | 9.46% |
| 2016 | $268.31M | 26.21% |
| 2015 | $212.60M | -3.94% |
| 2014 | $221.32M | 67.37% |
| 2013 | $132.24M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 724.12% |
IN
|
